| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Victoria Vakiener is Director at ARWR. Victoria Vakiener's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.1M at current prices.
Historically, Victoria Vakiener's trades have earned a middling insider score of 53/100 across 5 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +4.5%.
The ARWR filings lean toward selling, a net 27,103 shares.
Victoria Vakiener has 9 Form 4 filings on record from January 2023 to December 2025, all as Director at Arrowhead Pharmaceuticals (ARWR), 2023–2025.
The 14 reported transactions were 8 open-market sales, 4 stock awards, 1 disposition back to the company and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $1.1M.
The largest open-market sale was 10,040 shares of ARWR at an average $67.68 on December 19, 2025, about $679K.
4 of the 5 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 10,040 | $67.68 | $679,491.34 | -21.9% | -16.4% | - | |
| Dec 16, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 8,994 | $21.91 | $197,058.54 | -29.8% | -30.3% | +189.0% | |
| May 2, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 1,799 | $23.31 | $41,934.69 | -5.6% | +18.4% | -40.2% | |
| Jan 11, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 4,720 | $38.10 | $179,813.40 | -12.9% | -32.3% | -50.7% | |
| Sep 28, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 1,550 | $26.33 | $40,811.50 | -6.7% | +15.2% | -27.0% |